This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Tegafur

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Tegafur Means in Everyday Medical Language

Tegafur is a chemotherapy drug that belongs to a group called antimetabolites. It is a prodrug, which means it changes inside the body into an active cancer-fighting substance called 5-fluorouracil (5-FU). 5-FU works by interfering with the cancer cells’ ability to grow and divide. Tegafur is often combined with another substance called uracil to form a drug combination known as tegafur/uracil, UFT, or Ftorafur. Uracil helps increase the amount of 5-FU inside cancer cells, making the treatment more effective and sometimes reducing side effects.

Why Tegafur Can Matter in Cancer Care

Tegafur is mainly used to treat bowel (colorectal) cancer but is also studied and used for other cancers such as stomach, lung, breast, liver, and pancreatic cancers. In some countries, including the UK, tegafur/uracil combined with folinic acid is approved as a first treatment option for metastatic colorectal cancer. Because it is taken by mouth, some patients prefer it over intravenous chemotherapy. Understanding tegafur helps patients and caregivers recognize its role in treatment plans and discussions.

What Patients Might See or Hear About Tegafur

You might come across the term tegafur or its related names like Ftorafur, UFT, or tegafur-uracil in medical reports, visit notes, treatment plans, or educational materials. These names all refer to the same or very similar drug combinations. Because these terms can be confusing, it’s important to ask your healthcare team what they mean for your specific care. Seeing the name alone does not tell you about your cancer type, stage, or prognosis.

Common Sources of Confusion and How to Read Tegafur in Context

Tegafur, Ftorafur, UFT, and tegafur-uracil are often used interchangeably, which can be confusing. Also, because these are drug names, they do not provide information about your diagnosis or treatment plan by themselves. The safest approach is to ask your care team how this drug fits into your overall treatment. Don’t assume that seeing the name means a specific treatment is planned or that it applies to you without clarification.

Practical Questions to Ask Your Care Team

If you hear about tegafur or its related names, you might ask: What type of cancer is this drug used for? How does it work? Is it part of my treatment plan? What are the possible side effects? Are there other treatment options? These questions can help you feel more informed and involved in your care decisions.

How to Read the Term in Context and Safety Notes

This information is meant to help you understand what tegafur is and why it might be mentioned in your care. It does not replace advice from your healthcare team. Every patient’s situation is unique, so the best next step is to talk with your doctors or nurses about what this drug means for you personally. They can explain how it fits into your diagnosis, treatment, or follow-up care and answer any questions you have.

Sources

Public source information used for this glossary entry includes: